These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 19411283
1. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy. Christensen LP, Zhang RL, Zheng W, Campanelli JJ, Dedkov EI, Weiss RM, Tomanek RJ. Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H322-30. PubMed ID: 19411283 [Abstract] [Full Text] [Related]
3. Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen. Dedkov EI, Zheng W, Christensen LP, Weiss RM, Mahlberg-Gaudin F, Tomanek RJ. Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H590-8. PubMed ID: 17384136 [Abstract] [Full Text] [Related]
4. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure. Dedkov EI, Bogatyryov Y, McCooey DS, Christensen LP, Weiss RM, Tomanek RJ. J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895 [Abstract] [Full Text] [Related]
5. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure. Milliez P, Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C. Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674 [Abstract] [Full Text] [Related]
6. Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction. Langenbach MR, Schmitz-Spanke S, Brockert M, Schepan M, Pomblum VJ, Gams E, Zirngibl H, Schipke JD. J Cardiovasc Surg (Torino); 2006 Dec; 47(6):719-25. PubMed ID: 17043621 [Abstract] [Full Text] [Related]
7. Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart. Dedkov EI, Christensen LP, Weiss RM, Tomanek RJ. Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2684-93. PubMed ID: 15681710 [Abstract] [Full Text] [Related]
8. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart. Maczewski M, Mackiewicz U. Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678 [Abstract] [Full Text] [Related]
9. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003 [Abstract] [Full Text] [Related]
10. Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. Ceconi C, Comini L, Suffredini S, Stillitano F, Bouly M, Cerbai E, Mugelli A, Ferrari R. Am J Physiol Heart Circ Physiol; 2011 Jan 06; 300(1):H366-73. PubMed ID: 20952661 [Abstract] [Full Text] [Related]
11. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Circulation; 1994 May 06; 89(5):2273-82. PubMed ID: 8181153 [Abstract] [Full Text] [Related]
12. Ivabradine protects rats against myocardial infarction through reinforcing autophagy via inhibiting PI3K/AKT/mTOR/p70S6K pathway. Dai Y, Chen Y, Wei G, Zha L, Li X. Bioengineered; 2021 Dec 06; 12(1):1826-1837. PubMed ID: 33975512 [Abstract] [Full Text] [Related]
13. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, van Veldhuisen DJ. Cardiovasc Res; 2003 Feb 06; 57(2):434-42. PubMed ID: 12566116 [Abstract] [Full Text] [Related]
14. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Suffredini S, Stillitano F, Comini L, Bouly M, Brogioni S, Ceconi C, Ferrari R, Mugelli A, Cerbai E. Br J Pharmacol; 2012 Mar 06; 165(5):1457-66. PubMed ID: 21838751 [Abstract] [Full Text] [Related]
15. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris. Li Y, Jing L, Li Y, Jiang J, Wang Z, Wei J, Li X, Wang L, Xia H, Li T, Liu S, Xing B, Yang Z, Lu Q, Jiang R, Xie P, Shou X, Wang X, Jia Y. Pharmacoepidemiol Drug Saf; 2014 Nov 06; 23(11):1183-91. PubMed ID: 24757084 [Abstract] [Full Text] [Related]
17. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study. Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P. Arch Cardiovasc Dis; 2014 Jan 06; 107(1):33-41. PubMed ID: 24440004 [Abstract] [Full Text] [Related]